Eli Lilly and Company (NYSE: LLY) announced positive topline results from the Phase III BRUIN...
Sanofi SA (NASDAQ: SNY) announced that the European Commission (EC) has granted marketing authorization for...
AstraZeneca plc (NYSE: AZN) has secured marketing approval from China’s National Medical Products Administration (NMPA)...
RemeGen Ltd. (HKG: 9995) has announced that China’s National Medical Products Administration (NMPA) has approved...
Shanghai Henlius Biotech, Inc. (HKG: 2696) has announced the dosing of the first subject in...
AbbVie Inc. (NYSE: ABBV) has announced that China’s National Medical Products Administration (NMPA) has approved...
IASO Biotherapeutics, a Chinese cell therapy innovator, has entered into a strategic technology collaboration and...
CanSino Biologics Inc. (HKG: 6185) has announced that China’s National Medical Products Administration (NMPA) has...
Zhejiang Medicine Co., Ltd. (SHA: 600216) has announced its strategic intention to spin off its...
Cutia Therapeutics (HKG: 2487) has announced the successful completion of its pivotal Phase III clinical...
Hotgen Biotech Co., Ltd. (SHA: 688068) has announced that the National Medical Products Administration (NMPA)...
Haisco Pharmaceutical Group Co., Ltd. (SHE: 002653) has entered into a strategic exclusive licensing agreement...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX), the Australian partner of Grand Pharmaceutical Group Co.,...
GlaxoSmithKline plc (GSK, NYSE: GSK) has reported highly promising data from the global Phase I...
Merck KGaA (ETR: MRK) has officially closed its acquisition of the chromatography business from JSR...
Boehringer Ingelheim and BioNTech SE (NASDAQ: BNTX) have announced a clinical collaboration to evaluate a...
Gaush Meditech Ltd. (HKG: 2407), a Chinese innovator in ophthalmic medical devices, has announced it...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has announced a definitive agreement to acquire fellow U.S. biopharmaceutical...
Nanjing Pharmaceutical Group Co., Ltd. (SHA: 600713) has unveiled a strategic plan to establish a...
Telix Pharmaceuticals Ltd. (ASX: TLX) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) have announced a strategic...